PMC:7291971 / 19905-20072
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T451 | 9-17 | CHEBI:36357;CHEBI:36357 | denotes | compound |
| T452 | 58-63 | PR:O43148 | denotes | hRNMT |
| T453 | 89-94 | NCBITaxon:10239 | denotes | viral |
| T454 | 143-148 | SP_6;NCBITaxon:9606 | denotes | human |
| T455 | 153-158 | NCBITaxon:10239 | denotes | viral |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T165 | 35-36 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T166 | 113-114 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T167 | 143-148 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T141 | 0-167 | Sentence | denotes | However, compound 2 also displayed a potent inhibition of hRNMT in the same range as the viral MTases displaying a lack of specificity against human and viral enzymes. |